For more information or confidential assistance
Call 800-306-3180

FDA’s Pradaxa Study Criticized

The Food and Drug Administration recently released a report that showed that the bleeding risks of Pradaxa are comparable to the risks associated with a competing, older drug, known as warfarin. Many patients are skeptical of this report, as the Food and Drug Administration relied... Read More